Biorestorative Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

+0.02 (+1.96%)

As of Feb 8, 2:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +2,416.3% upside

Low Target $18.72

Average Target $26.17

High Target $39.89

Current Price $1.04

Current
$1.04

Target
$26.17

$18.72 $26.17 avg $39.89

Scenario Analysis

Bear Case

$18.72

1,700.0%

Low target

Base Case

$26.17

+2,416.3%

Avg target

Bull Case

$39.89

+3,735.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$26.91

-96.1% from high

52-Week Low

$20.27

+-94.9% from low

Target vs 52W High

$26.17

-2.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%